Swiss Medtech company Implantica plans IPO on Nasdaq First North (Sweden), not on Swiss Stock Exchange SIX. Founder & Director Peter Forsell Reason explains: little interest in Switzerland and much higher interest in Sweden.
SIX seems to be unattractiv for Medtech: In the last two years IPOs of Swiss Medtech companies weren’t convincing: Medartis & Medacta International are two well known companies which went public and did not satisfy the expectations.
Source: Reuters
